A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Conditions
Interventions
- PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation
- DRUG: Asparaginase Erwinia chrysanthemi
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Bone Marrow Aspiration
- PROCEDURE: Bone Marrow Biopsy
- PROCEDURE: Computed Tomography
- DRUG: Cytarabine
- DRUG: Daunorubicin Hydrochloride
- DRUG: Dexrazoxane Hydrochloride
- DRUG: Etoposide
- OTHER: Fludeoxyglucose F-18
- DRUG: Gemtuzumab Ozogamicin
- DRUG: Gilteritinib Fumarate
- DRUG: Liposome-encapsulated Daunorubicin-Cytarabine
- PROCEDURE: Magnetic Resonance Imaging
- DRUG: Methotrexate
- DRUG: Mitoxantrone Hydrochloride
- PROCEDURE: Positron Emission Tomography
- OTHER: Questionnaire Administration
- DRUG: Therapeutic Hydrocortisone
Sponsor
Children's Oncology Group
Collaborators